Roopa Industries Ord B is trading -1.90% lower at Rs 56.90 as compared to its last closing price. Roopa Industries Ord B has been trading in the price range of 58.00 & 55.60. Roopa Industries Ord B has given -22.21% in this year & 1.83% in the last 5 days. Roopa Industries Ord B has TTM P/E ratio 27.82 as compared to the sector P/E of 18.30.The company posted a net profit of 0.76 Crores in its last quarter.Listed peers of Roopa Industries Ord B include Chandra Bhagat Pharma (-%), Gujarat Terce Laboratories Ord T (2.41%), Roopa Industries Ord B (-1.90%).The Mutual Fund holding in Roopa Industries Ord B was at -% in . The MF holding has - from the last quarter. The FII holding in Roopa Industries Ord B was at -% in . The FII holding has - from the last quarter.
Updated on Mar 22, 2025, 08:52 AM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Chandra Bhagat Pharma | Neutral | 65.00 | - | 49.04 | 30.88 | 1.69 | - | 4.87 |
Gujarat Terce Laboratories Ord T | Bearish | 67.50 | 2.41 | 50.09 | 200.93 | 6.88 | - | 13.05 |
Roopa Industries Ord B | Bearish | 56.90 | -1.90 | 47.45 | 30.03 | 2.95 | - | 34.12 |
Medico Intercontinental | Moderately Bearish | 41.40 | -1.38 | 41.53 | 10.63 | 0.93 | - | 4.15 |
Gujarat Inject Kerala Ord B | Bullish | 27.79 | -0.75 | 40.71 | 311.11 | 3.7 | - | - |
Meeting Date | Purpose |
---|---|
2025-02-14 | Quarterly Results |
2024-11-14 | Quarterly Results |
2024-08-14 | Quarterly Results |
2024-05-30 | Audited Results |
2024-02-12 | Quarterly Results |
Roopa Industries Ord B is trading at 56.90 as on Fri Mar 21 2025 09:53:17. This is -1.90% lower as compared to its previous closing price of 58.00.
The market capitalization of Roopa Industries Ord B is 47.45 Cr as on Fri Mar 21 2025 09:53:17.
The 52 wk high for Roopa Industries Ord B is 114.90 whereas the 52 wk low is 50.25
Roopa Industries Ord B can be analyzed on the following key metrics -
Roopa Industries Ord B reported a net profit of 1.52 Cr in 2024.